| 1.4 |
4.1 |
GO:0050894 |
determination of affect(GO:0050894) |
| 1.3 |
5.1 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.2 |
3.5 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.9 |
5.6 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.9 |
0.9 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.9 |
2.7 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.8 |
3.1 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.8 |
3.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.8 |
4.7 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.8 |
4.6 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.7 |
2.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.6 |
1.9 |
GO:1905064 |
negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.6 |
1.8 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.6 |
1.8 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.6 |
7.0 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.6 |
1.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.5 |
3.3 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.5 |
1.6 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.5 |
1.6 |
GO:0060929 |
Purkinje myocyte differentiation(GO:0003168) septum secundum development(GO:0003285) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
| 0.5 |
1.5 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.5 |
4.0 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.5 |
2.4 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.5 |
1.4 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.5 |
11.3 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.4 |
4.5 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 |
4.6 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.4 |
1.3 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.4 |
1.3 |
GO:1904395 |
positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 |
4.5 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.4 |
1.2 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.4 |
1.2 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 0.4 |
1.2 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.4 |
1.9 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.4 |
1.9 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.4 |
1.2 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.4 |
0.4 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.4 |
0.4 |
GO:0060458 |
right lung development(GO:0060458) |
| 0.4 |
1.1 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.4 |
0.4 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.4 |
0.4 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.4 |
2.2 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
1.1 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.4 |
0.4 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.3 |
0.7 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.3 |
1.3 |
GO:1990927 |
vesicle-mediated cholesterol transport(GO:0090119) calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.3 |
1.3 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 |
1.9 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
0.6 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.3 |
1.3 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.3 |
1.6 |
GO:0071874 |
cellular response to norepinephrine stimulus(GO:0071874) |
| 0.3 |
0.3 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.3 |
3.1 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.3 |
2.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.3 |
0.3 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.3 |
1.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 |
0.3 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.3 |
1.4 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.3 |
0.8 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.3 |
1.4 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.3 |
1.4 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.3 |
1.4 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 |
0.8 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 |
0.8 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.3 |
1.3 |
GO:1903597 |
negative regulation of gap junction assembly(GO:1903597) |
| 0.3 |
0.3 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.3 |
2.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.3 |
0.5 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 |
1.8 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.3 |
1.3 |
GO:0031296 |
positive regulation of germinal center formation(GO:0002636) B cell costimulation(GO:0031296) |
| 0.3 |
0.8 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.3 |
0.5 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.3 |
1.5 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 |
0.7 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.2 |
1.2 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.2 |
1.0 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.2 |
1.7 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 |
3.4 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
3.7 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.2 |
0.7 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.2 |
1.0 |
GO:1904800 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 |
1.4 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.2 |
0.7 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
0.2 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.2 |
0.2 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.2 |
4.6 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
0.7 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.2 |
0.2 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 |
0.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
0.7 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.2 |
1.5 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.2 |
0.2 |
GO:0060775 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 0.2 |
0.4 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.2 |
0.6 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.2 |
0.9 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
1.1 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 |
0.6 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.2 |
0.8 |
GO:0007622 |
rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.2 |
0.6 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.2 |
0.6 |
GO:0002019 |
regulation of renal output by angiotensin(GO:0002019) |
| 0.2 |
1.7 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) |
| 0.2 |
0.6 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.2 |
0.6 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
1.2 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
0.4 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
1.4 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.2 |
0.6 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.2 |
0.8 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 |
0.6 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.2 |
1.1 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.2 |
0.2 |
GO:2000532 |
renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) |
| 0.2 |
1.1 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.2 |
0.6 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 |
0.2 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.2 |
0.7 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
0.6 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.2 |
0.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
1.7 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.2 |
0.4 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 |
0.7 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
1.5 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
0.5 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.2 |
1.6 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.2 |
1.1 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
0.5 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.2 |
3.9 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
0.5 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.2 |
2.0 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 |
0.2 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.2 |
0.2 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.2 |
0.5 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.2 |
2.1 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 |
0.3 |
GO:0048668 |
collateral sprouting(GO:0048668) |
| 0.2 |
0.9 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.5 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.2 |
0.7 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.2 |
0.7 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.2 |
0.2 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.2 |
0.2 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 |
0.3 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 |
0.5 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.2 |
1.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 |
1.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.5 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 |
0.7 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 |
0.8 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.2 |
0.6 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 |
0.8 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.2 |
2.1 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 |
1.0 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 |
1.0 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.2 |
0.5 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.2 |
1.9 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
1.9 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.2 |
0.5 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.2 |
0.6 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.2 |
0.5 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.2 |
1.6 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.2 |
1.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
0.6 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.2 |
1.7 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.2 |
0.9 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
3.5 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
0.9 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.2 |
0.3 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
1.0 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
2.5 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.9 |
GO:0061188 |
negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 |
0.4 |
GO:1904617 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.1 |
0.1 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.1 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.3 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.1 |
3.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
2.3 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.6 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.1 |
1.4 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.6 |
GO:2000569 |
T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.1 |
0.6 |
GO:0032971 |
regulation of muscle filament sliding(GO:0032971) |
| 0.1 |
0.6 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
2.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.7 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
4.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.6 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
1.3 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
0.4 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.1 |
0.3 |
GO:0021861 |
forebrain radial glial cell differentiation(GO:0021861) |
| 0.1 |
0.4 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
2.4 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.1 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
0.4 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
0.7 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 0.1 |
0.6 |
GO:0032606 |
type I interferon production(GO:0032606) |
| 0.1 |
0.3 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.1 |
0.7 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 |
0.4 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
0.4 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.1 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.1 |
0.7 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.5 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.1 |
0.9 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.1 |
1.7 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 |
0.1 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.1 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.1 |
6.9 |
GO:0090102 |
cochlea development(GO:0090102) |
| 0.1 |
0.5 |
GO:1901558 |
regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.1 |
0.1 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.1 |
0.6 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.4 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.1 |
1.6 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.1 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.1 |
3.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.8 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 |
0.4 |
GO:0042137 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) sequestering of neurotransmitter(GO:0042137) |
| 0.1 |
0.8 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
1.0 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.1 |
1.0 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 |
1.1 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
0.1 |
GO:0046889 |
positive regulation of lipid biosynthetic process(GO:0046889) |
| 0.1 |
0.4 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
1.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.4 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 |
0.9 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
2.2 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
2.8 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 |
0.6 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.1 |
2.4 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
1.0 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.5 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.1 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.8 |
GO:0042177 |
negative regulation of protein catabolic process(GO:0042177) |
| 0.1 |
0.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.1 |
0.2 |
GO:0070245 |
positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 |
0.4 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.1 |
0.2 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
1.0 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.1 |
0.5 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.1 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.2 |
GO:0003151 |
outflow tract morphogenesis(GO:0003151) |
| 0.1 |
0.5 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 |
0.3 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.1 |
0.3 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.1 |
0.5 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 |
0.3 |
GO:0045083 |
negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.1 |
0.5 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 |
0.5 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 |
0.3 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.1 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
0.4 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.2 |
GO:0021942 |
hindbrain radial glia guided cell migration(GO:0021932) radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.3 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.1 |
0.8 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.1 |
1.1 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.4 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.4 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.1 |
0.1 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
0.3 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
1.6 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
3.4 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 |
1.8 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.2 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.1 |
0.5 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.1 |
0.6 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.1 |
0.6 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.3 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
0.4 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.1 |
0.9 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.1 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.1 |
0.4 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
0.2 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.1 |
0.3 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.1 |
0.4 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 |
0.6 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.5 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.3 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.7 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.4 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.2 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) peptidyl-glutamic acid modification(GO:0018200) protein carboxylation(GO:0018214) |
| 0.1 |
0.9 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.3 |
GO:0051785 |
positive regulation of nuclear division(GO:0051785) |
| 0.1 |
0.5 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 |
0.5 |
GO:0061015 |
snRNA import into nucleus(GO:0061015) |
| 0.1 |
1.1 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 |
0.3 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.1 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.1 |
0.8 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.5 |
GO:0045661 |
regulation of myoblast differentiation(GO:0045661) |
| 0.1 |
0.4 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.2 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
0.1 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.1 |
0.6 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.4 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
0.2 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 |
0.4 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.1 |
0.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.4 |
GO:0022406 |
membrane docking(GO:0022406) |
| 0.1 |
0.5 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.1 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.1 |
6.0 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.4 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.1 |
1.8 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 |
0.4 |
GO:0061037 |
negative regulation of cartilage development(GO:0061037) |
| 0.1 |
0.2 |
GO:0098727 |
maintenance of cell number(GO:0098727) |
| 0.1 |
2.6 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
1.2 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
2.8 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.4 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.8 |
GO:0043634 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.4 |
GO:0046502 |
uroporphyrinogen III biosynthetic process(GO:0006780) succinyl-CoA pathway(GO:0006781) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.1 |
0.7 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
0.8 |
GO:0036376 |
sodium ion export from cell(GO:0036376) |
| 0.1 |
0.1 |
GO:0046822 |
regulation of nucleocytoplasmic transport(GO:0046822) |
| 0.1 |
0.3 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.1 |
1.9 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 |
0.2 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.6 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
0.3 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.3 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.1 |
0.9 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.1 |
0.2 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
0.3 |
GO:1901340 |
negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.1 |
1.2 |
GO:0003356 |
regulation of cilium beat frequency(GO:0003356) |
| 0.1 |
0.6 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.1 |
0.8 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
0.7 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
1.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.1 |
0.2 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) |
| 0.1 |
0.2 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.1 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.2 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.1 |
0.4 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
1.5 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.1 |
GO:0035815 |
positive regulation of renal sodium excretion(GO:0035815) |
| 0.1 |
0.6 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.2 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
0.2 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.1 |
1.4 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
9.0 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 |
0.5 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.5 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 |
0.3 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 |
0.2 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
0.2 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 |
0.4 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 |
0.1 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 |
1.0 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.4 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.3 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.1 |
0.3 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 |
0.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.1 |
0.3 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.7 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.9 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 |
0.2 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.1 |
0.3 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.1 |
0.1 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.1 |
0.6 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.6 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.1 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 |
0.4 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 |
0.8 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.1 |
0.1 |
GO:0060907 |
regulation of macrophage cytokine production(GO:0010935) positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
1.7 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.6 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.2 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 0.1 |
0.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
0.1 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.1 |
0.4 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.2 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.1 |
0.6 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.4 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
0.4 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.7 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
0.3 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.1 |
0.2 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 |
0.7 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.9 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.2 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
0.1 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 |
0.7 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 |
0.8 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
0.5 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
0.1 |
GO:0071317 |
cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 |
0.3 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
0.2 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.1 |
0.5 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
0.3 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.1 |
0.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
0.1 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 |
0.3 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 |
0.3 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 |
0.5 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.1 |
0.4 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.1 |
0.1 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) |
| 0.1 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.1 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 0.1 |
0.1 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.5 |
GO:0045007 |
depurination(GO:0045007) |
| 0.1 |
0.2 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 |
0.3 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.3 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.1 |
0.3 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.1 |
0.6 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.1 |
0.2 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.1 |
0.2 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.1 |
0.1 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.6 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
0.4 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
0.4 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.5 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.3 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 0.1 |
0.4 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.2 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.1 |
1.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
1.2 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
1.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
1.0 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.2 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 |
1.5 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 |
0.2 |
GO:0021571 |
rhombomere 5 development(GO:0021571) |
| 0.1 |
0.4 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.1 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.2 |
GO:1903979 |
negative regulation of microglial cell activation(GO:1903979) |
| 0.1 |
0.2 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.1 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 |
0.3 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.1 |
0.2 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.1 |
0.4 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.1 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.4 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.2 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.1 |
0.2 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.1 |
0.4 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.1 |
GO:0043103 |
hypoxanthine salvage(GO:0043103) |
| 0.1 |
0.2 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 |
0.6 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 0.1 |
0.1 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.1 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
1.5 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.1 |
0.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.2 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) homoserine metabolic process(GO:0009092) cysteine biosynthetic process via cystathionine(GO:0019343) transsulfuration(GO:0019346) |
| 0.1 |
0.6 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
2.5 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.1 |
1.0 |
GO:0050812 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 |
0.1 |
GO:0045626 |
negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.1 |
0.5 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 |
0.4 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.1 |
0.7 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.4 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.1 |
0.1 |
GO:0021896 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 |
0.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
1.7 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
0.2 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.1 |
0.9 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.5 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.2 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 |
0.1 |
GO:0036124 |
histone H3-K9 trimethylation(GO:0036124) |
| 0.1 |
0.1 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
0.2 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
0.3 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.3 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.1 |
0.2 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 |
0.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.3 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.7 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.4 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.1 |
0.1 |
GO:0003140 |
determination of left/right asymmetry in lateral mesoderm(GO:0003140) |
| 0.1 |
0.2 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 |
0.3 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.1 |
0.1 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.1 |
0.2 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.1 |
0.1 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
| 0.1 |
0.3 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.5 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.1 |
0.1 |
GO:0031645 |
negative regulation of myelination(GO:0031642) negative regulation of neurological system process(GO:0031645) |
| 0.1 |
0.1 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
0.3 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.2 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 |
0.1 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.2 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
2.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.2 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.1 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.0 |
0.1 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.0 |
1.6 |
GO:0019079 |
viral genome replication(GO:0019079) |
| 0.0 |
0.1 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.0 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.4 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.0 |
1.6 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.0 |
0.2 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.0 |
0.1 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.0 |
0.2 |
GO:1901033 |
positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.0 |
0.2 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.3 |
GO:0048741 |
skeletal muscle fiber development(GO:0048741) |
| 0.0 |
0.2 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.0 |
0.1 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.0 |
1.8 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.1 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.0 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.0 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.2 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.0 |
0.7 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.2 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.0 |
0.1 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 0.0 |
0.2 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
0.2 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
2.0 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
0.1 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.0 |
0.3 |
GO:0001999 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.0 |
0.4 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.0 |
0.3 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.0 |
0.4 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.1 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.0 |
0.4 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.4 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.1 |
GO:0046452 |
dihydrofolate metabolic process(GO:0046452) |
| 0.0 |
0.1 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.0 |
0.1 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.0 |
0.3 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.9 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.0 |
0.6 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.3 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.7 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.2 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.1 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.0 |
0.2 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.0 |
4.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0042421 |
norepinephrine biosynthetic process(GO:0042421) |
| 0.0 |
0.1 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.4 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 |
0.0 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 |
0.6 |
GO:0045329 |
amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 0.0 |
0.2 |
GO:1904823 |
pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.0 |
0.2 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.0 |
0.2 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
1.1 |
GO:0031111 |
negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
| 0.0 |
0.7 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.4 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.4 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.0 |
0.3 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.0 |
0.5 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.1 |
GO:0060556 |
regulation of vitamin D biosynthetic process(GO:0060556) |
| 0.0 |
0.5 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.0 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.0 |
0.2 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.4 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.0 |
2.0 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.6 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.1 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.0 |
0.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.2 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.1 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.0 |
0.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.4 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.1 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
0.2 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 |
0.1 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) |
| 0.0 |
0.6 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.3 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.0 |
0.0 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 |
0.3 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.6 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.4 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.0 |
0.1 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.0 |
0.2 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.1 |
GO:0051153 |
regulation of striated muscle cell differentiation(GO:0051153) |
| 0.0 |
0.2 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 |
0.1 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.0 |
0.1 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.0 |
0.0 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
0.0 |
GO:0045714 |
regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.0 |
2.1 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.0 |
0.8 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.0 |
0.3 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.2 |
GO:0014038 |
regulation of Schwann cell differentiation(GO:0014038) |
| 0.0 |
0.1 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.0 |
0.1 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.0 |
0.2 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
0.2 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 |
0.5 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.0 |
0.1 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.0 |
2.2 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.2 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.0 |
0.0 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.0 |
0.2 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.0 |
0.2 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.0 |
0.2 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.0 |
0.1 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.1 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.0 |
0.7 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.1 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.0 |
0.1 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.0 |
0.2 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.0 |
0.2 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
1.9 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.3 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.0 |
0.0 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.0 |
0.5 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.0 |
0.5 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:0097155 |
determination of digestive tract left/right asymmetry(GO:0071907) fasciculation of sensory neuron axon(GO:0097155) |
| 0.0 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.4 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.1 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
| 0.0 |
0.3 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.0 |
0.5 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.1 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.0 |
0.2 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.0 |
0.1 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.1 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.0 |
0.1 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.0 |
0.1 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.0 |
0.4 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.3 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.0 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.0 |
0.4 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 |
0.2 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.0 |
0.0 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.2 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.2 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.1 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 |
0.7 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.2 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 |
0.2 |
GO:0042262 |
DNA protection(GO:0042262) |
| 0.0 |
0.2 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 |
0.2 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 |
0.4 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.5 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.1 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.0 |
0.5 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.0 |
GO:1901205 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.0 |
0.0 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) negative regulation of interleukin-23 production(GO:0032707) |
| 0.0 |
0.2 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.0 |
0.2 |
GO:0045682 |
regulation of epidermis development(GO:0045682) |
| 0.0 |
1.4 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.0 |
0.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.0 |
0.2 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.0 |
0.5 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 |
0.1 |
GO:0003310 |
pancreatic A cell differentiation(GO:0003310) |
| 0.0 |
0.3 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.0 |
0.2 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 |
0.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.2 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
0.1 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.0 |
3.0 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.0 |
0.3 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.1 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.7 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.5 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.3 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
0.1 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.0 |
0.1 |
GO:0043132 |
NAD transport(GO:0043132) |
| 0.0 |
0.1 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.0 |
0.5 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 |
0.2 |
GO:0070099 |
regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.0 |
1.8 |
GO:0032392 |
DNA geometric change(GO:0032392) |
| 0.0 |
0.3 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 |
0.1 |
GO:0032431 |
activation of phospholipase A2 activity(GO:0032431) |
| 0.0 |
2.2 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.1 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.2 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.0 |
0.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 |
0.1 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.0 |
0.2 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.0 |
0.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.1 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.0 |
1.2 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.1 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.0 |
0.3 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.0 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.0 |
0.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.1 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.0 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.1 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.0 |
0.1 |
GO:0097049 |
motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) |
| 0.0 |
0.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.1 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.5 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.2 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.6 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.0 |
0.2 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.2 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.0 |
0.2 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.0 |
0.3 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.4 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.3 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.1 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.0 |
0.2 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.0 |
0.0 |
GO:2001293 |
malonyl-CoA metabolic process(GO:2001293) |
| 0.0 |
0.1 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.0 |
0.2 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.5 |
GO:0050851 |
antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.0 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.0 |
0.1 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.0 |
0.1 |
GO:1904894 |
positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
| 0.0 |
0.2 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.0 |
0.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
2.9 |
GO:0008652 |
cellular amino acid biosynthetic process(GO:0008652) |
| 0.0 |
0.1 |
GO:0072331 |
signal transduction by p53 class mediator(GO:0072331) |
| 0.0 |
0.7 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.0 |
0.1 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
0.2 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.2 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.1 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.0 |
0.3 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 |
0.1 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.0 |
0.9 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.5 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0072684 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.0 |
1.2 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.2 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.5 |
GO:0010952 |
positive regulation of peptidase activity(GO:0010952) |
| 0.0 |
0.2 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.0 |
0.1 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.0 |
0.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.1 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 |
0.2 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.0 |
0.4 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.3 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.1 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.0 |
0.0 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.4 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.0 |
0.0 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 |
0.0 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.0 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) |
| 0.0 |
0.6 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.1 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.0 |
0.1 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 |
0.8 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 |
0.0 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.6 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.4 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 |
0.2 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.3 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.0 |
0.3 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
0.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 |
0.4 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.0 |
GO:0010159 |
specification of organ position(GO:0010159) |
| 0.0 |
0.5 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.4 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.0 |
0.2 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.2 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.0 |
0.1 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.0 |
0.4 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.0 |
0.1 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.0 |
0.3 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 |
0.3 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.2 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.7 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.0 |
0.0 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.2 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.1 |
GO:0030859 |
polarized epithelial cell differentiation(GO:0030859) |
| 0.0 |
0.2 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.1 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.0 |
0.2 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.2 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
1.0 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
1.0 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.3 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.6 |
GO:0060323 |
head morphogenesis(GO:0060323) |
| 0.0 |
0.2 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.1 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.0 |
4.5 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.4 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 |
0.5 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.0 |
0.1 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.0 |
0.7 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.0 |
0.1 |
GO:0042593 |
carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
| 0.0 |
0.5 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 |
0.1 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.0 |
0.6 |
GO:0007031 |
peroxisome organization(GO:0007031) |
| 0.0 |
0.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 |
0.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.0 |
0.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 |
0.1 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
1.3 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.0 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.0 |
0.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.1 |
GO:0050993 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.0 |
0.1 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.0 |
0.2 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
2.0 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.0 |
4.5 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
| 0.0 |
0.1 |
GO:0070383 |
DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
| 0.0 |
0.0 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.0 |
0.0 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.1 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.1 |
GO:0051189 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.9 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.0 |
0.1 |
GO:0035307 |
positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.0 |
0.1 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.0 |
0.1 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.2 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.1 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
0.0 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.9 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.0 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.0 |
0.0 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.1 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.0 |
0.1 |
GO:0044179 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.0 |
0.2 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.4 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.4 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.1 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.0 |
0.4 |
GO:0002820 |
negative regulation of adaptive immune response(GO:0002820) |
| 0.0 |
0.0 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.0 |
0.3 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.1 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.1 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.0 |
0.1 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.4 |
GO:0010822 |
positive regulation of mitochondrion organization(GO:0010822) |
| 0.0 |
0.1 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 |
0.1 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.0 |
0.1 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.1 |
GO:0070863 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.1 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 0.0 |
0.1 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.0 |
0.0 |
GO:1902080 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.0 |
0.1 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.0 |
0.0 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.1 |
GO:0007588 |
excretion(GO:0007588) |
| 0.0 |
0.3 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.0 |
0.2 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 |
0.2 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.0 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.0 |
0.2 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.0 |
0.1 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.1 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.4 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 |
0.1 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.0 |
GO:0033260 |
nuclear DNA replication(GO:0033260) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 |
0.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.1 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.8 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.2 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.1 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.1 |
GO:0048298 |
regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 |
0.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.0 |
0.0 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.1 |
GO:0002793 |
positive regulation of peptide secretion(GO:0002793) |
| 0.0 |
0.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.2 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 |
0.0 |
GO:0019563 |
glycerol catabolic process(GO:0019563) |
| 0.0 |
0.2 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.0 |
0.1 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 |
1.2 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.0 |
0.1 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
1.3 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.1 |
GO:0021910 |
smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
| 0.0 |
0.1 |
GO:0097205 |
renal filtration(GO:0097205) |
| 0.0 |
0.3 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.0 |
0.1 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.0 |
0.1 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.1 |
GO:0098779 |
mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.0 |
0.0 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.0 |
0.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.7 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
0.2 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.1 |
GO:0097278 |
cytotoxic T cell degranulation(GO:0043316) complement-dependent cytotoxicity(GO:0097278) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 |
0.6 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.2 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.1 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.0 |
0.0 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.0 |
0.0 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.0 |
0.2 |
GO:0072182 |
regulation of nephron tubule epithelial cell differentiation(GO:0072182) metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.0 |
0.1 |
GO:0032966 |
negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.0 |
0.2 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.1 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 |
0.2 |
GO:0015866 |
ADP transport(GO:0015866) |
| 0.0 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.1 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.0 |
0.3 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.8 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.0 |
0.1 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
0.4 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.0 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.0 |
0.0 |
GO:0021877 |
forebrain neuron fate commitment(GO:0021877) |
| 0.0 |
0.1 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.0 |
3.7 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.0 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.4 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.2 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.0 |
0.1 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.0 |
0.0 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.0 |
0.1 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
0.1 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.0 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 0.0 |
0.0 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 |
0.0 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.0 |
0.1 |
GO:0019303 |
D-ribose metabolic process(GO:0006014) D-ribose catabolic process(GO:0019303) |
| 0.0 |
0.0 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.2 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.0 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.1 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.0 |
0.1 |
GO:0043302 |
positive regulation of leukocyte degranulation(GO:0043302) |
| 0.0 |
0.2 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.1 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.1 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.0 |
GO:0032594 |
protein transport within lipid bilayer(GO:0032594) |
| 0.0 |
0.0 |
GO:0044254 |
angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
| 0.0 |
0.0 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 |
0.3 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.4 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.0 |
0.1 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.4 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.7 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.2 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.1 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.0 |
0.1 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.0 |
0.2 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.5 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.2 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.0 |
0.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.2 |
GO:0071800 |
podosome assembly(GO:0071800) |
| 0.0 |
0.0 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.0 |
0.1 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
1.3 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.2 |
GO:0048713 |
regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 |
0.0 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.0 |
0.1 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.0 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.0 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.0 |
0.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.0 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
| 0.0 |
0.0 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.0 |
0.0 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.0 |
0.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.4 |
GO:0050954 |
sensory perception of mechanical stimulus(GO:0050954) |
| 0.0 |
0.1 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:1904353 |
regulation of telomere capping(GO:1904353) |
| 0.0 |
0.1 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.0 |
0.1 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.2 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.0 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.0 |
0.1 |
GO:1990089 |
response to nerve growth factor(GO:1990089) |
| 0.0 |
0.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.2 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.1 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.1 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
